Abstract
The aortitis syndrome is a chronic inflammatory process that affects the aorta and its primary branches. Patients with aortitis syndrome exhibit various ocular changes. We present a patient in whom cataract was the initial objective finding. The serum concentration of vascular endothelial growth factor, a cytokine that affects neovascularization, and vasopermeability, was elevated before the initiation of prednisolone treatment. Cataract should be considered as a possible characteristic initial finding in patients with aortitis syndrome. Vascular endothelial growth factor may be involved in the progression of aortitis syndrome.
MeSH terms
-
Adult
-
Alprostadil / analogs & derivatives
-
Alprostadil / therapeutic use
-
Angiography
-
Carotid Artery, Common / diagnostic imaging
-
Carotid Artery, Common / pathology
-
Cataract / blood
-
Cataract / complications
-
Cataract / diagnosis*
-
Endothelial Growth Factors / blood*
-
Female
-
Glucocorticoids / therapeutic use
-
Humans
-
Lymphokines / blood*
-
Prednisolone / therapeutic use
-
Subclavian Artery / diagnostic imaging
-
Subclavian Artery / pathology
-
Takayasu Arteritis / blood
-
Takayasu Arteritis / complications
-
Takayasu Arteritis / diagnosis*
-
Takayasu Arteritis / drug therapy
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
Substances
-
Endothelial Growth Factors
-
Glucocorticoids
-
Lymphokines
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
Prednisolone
-
Alprostadil
-
limaprost